Fig. 9

High-risk patients showed high expression of immune-checkpoint molecules and sensitivity to chemotherapies. A Correlation of risk scores and expression of immune-check points molecules. B Expression of immune-checkpoint molecules in low- and high-risk patients. C Sensitivity to chemotherapies of low- and high-risk patients. Low AUC values indicate higher sensitivity to chemotherapies